Autopsy report · NCT04285749

Prevention of Recurrence and Metastasis in Genetically High-Risk Melanomas

“PI moving to new institution prior to study activation”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Early Phase 1

Sponsor

Case Comprehensive Cancer Center

Sponsor type

University, hospital or other

Conditions

Malignant Melanoma

Interventions

Fluvastatin; RNA-sequencing; Gene expression profiling

Participants

0

Trials that died the same way

• International Study of High-Risk Patients for Hepatocellular Carcinoma Using Liquid Biopsy
  “PI moving on from current institution” (81% match in meaning)
• Isoflurane-induced Neuroinflammation in Children With Hydrocephalus
  “PI moving to another institution.” (77% match in meaning)
• Low Sodium vs. Regular Diet in Patients Admitted for Heart Failure
  “PI transferred to a new institution” (76% match in meaning)
• Effects of Sustained Reading on the Ocular Surface
  “PI is moving to a different institution.” (75% match in meaning)
• High-intensity Exercise After Treatment
  “Original PI moved to a new institution” (75% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.